Baicalin Mitigates Cardiac Hypertrophy and Fibrosis by Inhibiting the p85a Subunit of PI3K
<b>Background:</b> Heart failure (HF) is a serious public health concern. Baicalin is one of the major active ingredients of a traditional Chinese herbal medicine, Huang Qin, which is used to treat patients with chest pain or cardiac discomfort. However, the underlying mechanism(s) of th...
Saved in:
Main Authors: | Lu He, Min Zhu, Rui Yin, Liangli Dai, Juan Chen, Jie Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/232 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis
by: Xiaoming Li, et al.
Published: (2025-01-01) -
Effects of Baicalin on Gout Based on Network Pharmacology, Molecular Docking, and in vitro Experiments
by: Liu C, et al.
Published: (2025-02-01) -
Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis–A preclinical systematic review and meta-analysis
by: Jinchen Chong, et al.
Published: (2025-02-01) -
Genome-wide identification of the bHLH gene family in Scutellaria baicalensis and their relationship with baicalin biosynthesis under drought stress
by: Yingxin Sun, et al.
Published: (2025-01-01) -
Correction of Constricted Ear – Case Report
by: Ljubinka Damjanoska Krstikj, et al.
Published: (2024-06-01)